Stockreport

MediWound outlines $24M–$26M 2026 revenue target while expanding EscharEx clinical programs [Seeking Alpha]

MediWound Ltd. - Ordinary Shares  (MDWD) 
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mediwound.com/press-releases
PDF CEO Ofer Gonen indicated 2025 was a pivotal year for MediWound, highlighting two primary growth drivers: “a Phase III VALUE trial advancing as planned and an operationa [Read more]